Development and evaluation of the rivaroxaban loaded nanostructured lipid carriers for improved oral bioavailability and safety

Development and evaluation of the rivaroxaban loaded nanostructured lipid carriers for improved oral bioavailability and safety

Abstract A recent surge in deep vein thrombosis (DVT) has urged researchers to find potential candidates and new ways of drug delivery to treat the condition. Rivaroxaban (RIVA) is one of the active pharmaceutical agents used to treat DVT due to its unorthodox Xa-inhibiting therapeutic efficacy. How...

Full description

Saved in:
Bibliographic Details
Main Authors: Ali H. Alamri, Ghazala Ishrat, Fatima Zahid, Zakir Ali, Ali Alqahtani, Ahmed A. Lahiq, Shaker T. Alsharif, Mohammed A. Sahab, Fakhar ud Din
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Scientific Reports
Subjects:
Rivaroxaban
Nano lipid carriers
Deep vein thrombosis
Bioavailability
Toxicity
Online Access:https://doi.org/10.1038/s41598-025-06926-6
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-025-06926-6

Similar Items